ChemPartner’s immunologists specialize in in vitro assays spanning both adaptive and innate immune responses across a broad range of immune cell types. Our team brings deep expertise in immune cell activation, proliferation, and differentiation, as well as cytokine release, signal transduction, receptor binding, and cell–cell interaction. These capabilities have supported hundreds of global pharmaceutical and biotech clients in drug discovery for cancer immunotherapy and autoimmune diseases.
Beyond our extensive portfolio of phenotypic and functional in vitro models, client compounds can be further characterised through in vivo pharmacodynamic (PD) and pharmacological models of human disease. These cover a wide range of therapeutic areas, including respiratory inflammation, rheumatoid arthritis, multiple sclerosis, inflammatory skin and bowel diseases, and systemic inflammation. Complementing these models, our ex vivo analytical toolkit encompassing FACS, Luminex, QuantiGene, ELISPOT, and more provides multiple avenues for mechanistic understanding and biomarker discovery.
